SG11201608123VA - Pharmaceutical composition for external use - Google Patents

Pharmaceutical composition for external use

Info

Publication number
SG11201608123VA
SG11201608123VA SG11201608123VA SG11201608123VA SG11201608123VA SG 11201608123V A SG11201608123V A SG 11201608123VA SG 11201608123V A SG11201608123V A SG 11201608123VA SG 11201608123V A SG11201608123V A SG 11201608123VA SG 11201608123V A SG11201608123V A SG 11201608123VA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
external use
external
pharmaceutical
composition
Prior art date
Application number
SG11201608123VA
Inventor
Kazuyoshi Ado
Kozue Imai
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of SG11201608123VA publication Critical patent/SG11201608123VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201608123VA 2014-03-30 2015-03-26 Pharmaceutical composition for external use SG11201608123VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014070678A JP6580305B2 (en) 2014-03-30 2014-03-30 Pharmaceutical composition for external use
PCT/JP2015/059323 WO2015151990A1 (en) 2014-03-30 2015-03-26 Pharmaceutical composition for external use

Publications (1)

Publication Number Publication Date
SG11201608123VA true SG11201608123VA (en) 2016-11-29

Family

ID=54240316

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201810093PA SG10201810093PA (en) 2014-03-30 2015-03-26 Pharmaceutical composition for external use
SG11201608123VA SG11201608123VA (en) 2014-03-30 2015-03-26 Pharmaceutical composition for external use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201810093PA SG10201810093PA (en) 2014-03-30 2015-03-26 Pharmaceutical composition for external use

Country Status (6)

Country Link
JP (1) JP6580305B2 (en)
CN (1) CN106456598B (en)
MY (1) MY182059A (en)
SG (2) SG10201810093PA (en)
TW (1) TWI712408B (en)
WO (1) WO2015151990A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7086596B2 (en) * 2017-12-28 2022-06-20 小林製薬株式会社 External composition
JP7086597B2 (en) * 2017-12-28 2022-06-20 小林製薬株式会社 External composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5976013A (en) * 1982-10-23 1984-04-28 Toko Yakuhin Kogyo Kk Gelatinous pharmaceutical for surgical use
JP3044352B2 (en) * 1989-11-20 2000-05-22 ライオン株式会社 Patch
CA2058975C (en) * 1990-10-30 2000-06-06 Shuichi Kasai Antiinflammatory gel preparation
JP3100408B2 (en) * 1991-03-26 2000-10-16 株式会社資生堂 Skin external preparation containing diclofenac sodium
JPH11255644A (en) * 1998-03-09 1999-09-21 Lintec Corp Percutaneous absorption type antipyretic antiphlogistic analgesic
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
JP4820065B2 (en) * 2004-05-24 2011-11-24 同仁医薬化工株式会社 Anti-inflammatory analgesic topical aqueous solution
PE20060935A1 (en) * 2004-10-21 2006-10-26 Novartis Ag PHARMACEUTICAL COMPOSITION INCLUDING DICLOFENACO
CH699814B1 (en) * 2007-05-14 2010-05-14 Mepha Ag Diclofenac for topical application as a spray.
KR101517494B1 (en) * 2007-06-08 2015-05-04 트로이카 파마슈티칼스 리미티드 A novel non-aqueous topical solution of diclofenac and process for preparing the same
MX2011008095A (en) * 2009-01-30 2012-01-27 Kydes Pharmaceuticals Llc Transdermal delivery of diclofenac, carbamazepine and benzydamine.
JP5421063B2 (en) * 2009-10-23 2014-02-19 帝國製薬株式会社 Diclofenac sodium-containing aqueous patch
EP2753319B1 (en) * 2011-09-09 2018-04-11 Vizuri Health Sciences LLC A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof
JP6738120B2 (en) * 2013-03-29 2020-08-12 小林製薬株式会社 External pharmaceutical composition

Also Published As

Publication number Publication date
WO2015151990A1 (en) 2015-10-08
TWI712408B (en) 2020-12-11
SG10201810093PA (en) 2018-12-28
JP6580305B2 (en) 2019-09-25
MY182059A (en) 2021-01-18
JP2015189760A (en) 2015-11-02
CN106456598B (en) 2020-06-02
CN106456598A (en) 2017-02-22
TW201622712A (en) 2016-07-01

Similar Documents

Publication Publication Date Title
HK1225655A1 (en) Pharmaceutical compositions comprising azd9291
GB201618482D0 (en) Pharmaceutical compositions
GB201419257D0 (en) Pharmaceutical compositions
GB201409471D0 (en) Pharmaceutical composition
GB201402277D0 (en) Pharmaceutical compounds
GB201404922D0 (en) Pharmaceutical compounds
IL249553A0 (en) Pharmaceutical compositions
SG11201605366QA (en) Pharmaceutical composition containing pyridylaminoacetic acidcompound
GB201409488D0 (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
ZA201702086B (en) Long acting pharmaceutical compositions
GB201416513D0 (en) Pharmaceutical compounds
ZA201502073B (en) Pharmaceutical composition
IL250817A0 (en) Pharmaceutical compositions
ZA201508726B (en) Pharmaceutical composition
SG11201608123VA (en) Pharmaceutical composition for external use
PT3200772T (en) Pharmaceutical compositions comprising alpelisib
SI3089740T1 (en) Pharmaceutical composition
SG11201608124XA (en) Pharmaceutical composition for external use
SG10201504332VA (en) Pharmaceutical Composition
SG11201608122PA (en) Pharmaceutical composition for external use
SG2014014872A (en) Pharmaceutical compositions
GB201408432D0 (en) Pharmaceutical compositions
GB201404896D0 (en) Pharmaceutical compounds
GB201402278D0 (en) Pharmaceutical compounds